Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Literature
1.
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–6.CrossRefPubMed
2.
3.
Rastegari A, Rabbani M, Mirmohammad Sadeghi H, Faghih Imani E, Hasanzadeh A, Moazen F. Association of KCNJ11 (E23K) gene polymorphism with susceptibility to type 2 diabetes in Iranian patients. Adv Biomed Res. 2015;4(1).
4.
Inoue H, Ferrer J, Warren-Perry M, Zhang Y, Millns H, Turner RC, et al. Sequence variants in the pancreatic islet β-cell inwardly rectifying K+ channel Kir6. 2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes. 1997;46(3):502–7.CrossRefPubMed
Metadata
Title
Pharmacogenetic association of KCNJ11 (E23K) variant with therapeutic response to sulphonylurea (glibenclamide) in Iranian patients
Authors
Ali Rastegari
Mohammad Rabbani
Hamid Mirmohammad Sadeghi
Elham Faghih Imani
Akbar Hasanzadeh
Fatemeh Moazen
Publication date
01-12-2015
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0316-1

Other articles of this Issue 4/2015

International Journal of Diabetes in Developing Countries 4/2015 Go to the issue

Original Article

An exploratory analysis between dynamic change of metabolic syndrome and type 2 diabetes in a Chinese cohort

Original Article

Risk factors for proteinuria and renal insufficiency in Asian Indian patients with type 2 diabetes

Original Article

Selenium, zinc, and copper levels and their relation with HbA1c status in children with type 1 diabetes mellitus

Original Article

MC2, a new phosphodiesterase-3 inhibitor with antilipolytic and hypolipidemic effects in normal and diabetic rats

Original Article

The improvement of metabolic control after using metformin in patients with type 1 diabetes mellitus and excessive visceral fat tissue treated with intensive insulin therapy—pilot study

Editorial

The bitter taste of hypoglycemia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits